Statin therapy in patients with high and very high cardiovascular risk: an optimal approach
Open Access
- 14 November 2020
- journal article
- research article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (5) , 2696
Abstract
Статинотерапия у пациентов высокого и очень высокого сердечно-сосудистого риска: оптимальный подходKeywords
This publication has 32 references indexed in Scilit:
- Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countriesAtherosclerosis, 2019
- Effects of atorvastatin and rosuvastatin on renal function: A meta-analysisInternational Journal of Cardiology, 2013
- Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive ProteinJACC, 2010
- Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial designArchives of Cardiovascular Diseases, 2008
- The safety of rosuvastatin in comparison with other statins in over 100 000 statin users in UK primary carePharmacoepidemiology and Drug Safety, 2008
- Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical AtherosclerosisJAMA, 2007
- Effect of Very High-Intensity Statin Therapy on Regression of Coronary AtherosclerosisJAMA, 2006
- Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel-group, multicenter study (DISCOVERY Alpha study)Current Therapeutic Research, 2006
- Early and Late Benefits of High-Dose Atorvastatin in Patients With Acute Coronary SyndromesJACC, 2005
- Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) studyAmerican Heart Journal, 2004